Arrowstreet Capital’s Phibro Animal Health PAHC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.8M	Sell	86,782 -114,947	-57%	-$5.47M	﹤0.01%	1173
2025 Q4	$7.54M	Sell	201,729 -99,876	-33%	-$4.06M	﹤0.01%	1020
2025 Q3	$12.2M	Buy	301,605 +26,539	+10%	+$876K	0.01%	895
2025 Q2	$7.03M	Buy	275,066 +83,018	+43%	+$1.81M	0.01%	1028
2025 Q1	$4.1M	Sell	192,048 -130,042	-40%	-$2.91M	﹤0.01%	1082
2024 Q4	$6.76M	Buy	322,090 +84,599	+36%	+$1.96M	0.01%	929
2024 Q3	$5.35M	Buy	237,491 +85,636	+56%	+$1.65M	﹤0.01%	943
2024 Q2	$2.55M	Buy	151,855 +26,022	+21%	+$418K	﹤0.01%	1017
2024 Q1	$1.63M	Buy	125,833 +61,129	+94%	+$733K	﹤0.01%	1193
2023 Q4	$749K	Sell	64,704 -5,509	-8%	-$62.2K	﹤0.01%	1154
2023 Q3	$897K	Sell	70,213 -12,603	-15%	-$179K	﹤0.01%	1007
2023 Q2	$1.14M	Sell	82,816 -92,090	-53%	-$1.32M	﹤0.01%	947
2023 Q1	$2.68M	Buy	174,906 +39,441	+29%	+$603K	﹤0.01%	849
2022 Q4	$1.82M	Buy	135,465 +76,962	+132%	+$1.03M	﹤0.01%	891
2022 Q3	$778K	Buy	+58,503	New	+$1.01M	﹤0.01%	1031
2020 Q4	–	Sell	-55,453	Closed	-$965K	–	2470
2020 Q3	$965K	Buy	+55,453	New	+$1.18M	﹤0.01%	1823
2014 Q4	–	Sell	-13,589	Closed	-$305K	–	1308
2014 Q3	$305K	Buy	+13,589	New	+$272K	﹤0.01%	901